DataMEDS AI, Inc. MEDS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -78.16% | -51.59% | 27.55% | 478.87% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.16% | -51.59% | 27.55% | 478.87% | -- |
| Cost of Revenue | -54.71% | -20.92% | 81.92% | 503.87% | -- |
| Gross Profit | -345.00% | -382.48% | -463.63% | 416.41% | -- |
| SG&A Expenses | 12.98% | 21.58% | 952.65% | 1,944.70% | -- |
| Depreciation & Amortization | -14.76% | 44.20% | 188.09% | 553.77% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.88% | 5.26% | 330.63% | 1,057.46% | -- |
| Operating Income | -36.29% | -49.31% | -1,221.30% | -1,985.89% | -- |
| Income Before Tax | -94.86% | -95.35% | -1,377.12% | -2,059.46% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -94.86% | -95.35% | -1,377.12% | -2,059.46% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.86% | -95.35% | -1,377.12% | -2,059.46% | -- |
| EBIT | -36.29% | -49.31% | -1,221.30% | -1,985.89% | -- |
| EBITDA | -39.75% | -49.56% | -1,473.17% | -3,620.86% | -- |
| EPS Basic | -12.37% | -21.88% | -945.93% | -1,565.90% | -- |
| Normalized Basic EPS | 15.56% | -0.59% | -829.43% | -1,542.27% | -- |
| EPS Diluted | -12.37% | -21.88% | -945.93% | -1,565.90% | -- |
| Normalized Diluted EPS | 15.56% | -0.59% | -829.43% | -1,542.27% | -- |
| Average Basic Shares Outstanding | 91.73% | 72.99% | 51.55% | 28.90% | -- |
| Average Diluted Shares Outstanding | 91.73% | 72.99% | 51.55% | 28.90% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |